← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
159 ta ish
Ish: PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosis
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén +25
Maqola20172 iqtibosABIEfficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean‐Claude Tardif, Simon Kouz, David D. Waters +22
Maqola20192 iqtibosABITwo Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray, R. Scott Wright, David Kallend +8
Maqola20202 iqtibosABIColchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd +30
Maqola20202 iqtibosABIPCSK9 induces a pro-inflammatory response in macrophages
Chiara Ricci, Massimiliano Ruscica, Marina Camera +10
Maqola20182 iqtibosABIRole of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
Paolo Raggi, Jacques Genest, Jon T. Giles +4
Sharh maqola20182 iqtibosABIPCSK9 and inflammation: a review of experimental and clinical evidence
Amir Abbas Momtazi‐Borojeni, Sarvenaz Sabouri-Rad, Antonio M. Gotto +5
Sharh maqola20192 iqtibosABIThe role of long noncoding RNA in major human disease
Xiaoli Zhang, Ruiyun Hong, Weiqiang Chen +2
Sharh maqola20192 iqtibosABIProprotein Convertase Subtilisin/Kexin Type 9
Chiara Macchi, Nicola Ferri, Cesare R. Sirtori +3
Sharh maqola20212 iqtibosABITargeting inflammation in atherosclerosis — from experimental insights to the clinic
Sharh maqola20212 iqtibosABIHow the immune system shapes atherosclerosis: roles of innate and adaptive immunity
Payel Roy, Marco Orecchioni, Klaus Ley
Sharh maqola20212 iqtibosABIPCSK9-targeted therapies: present and future approaches
Mahmoud Al Rifai, Christie M. Ballantyne
Sharh maqola20212 iqtibosABIInflammation and atherosclerosis: signaling pathways and therapeutic intervention
Peng Kong, Ziyang Cui, Xiao-Fu Huang +3
Sharh maqola20222 iqtibosABI